What is the efficacy of QR678 for treating hair loss?

From the Guidelines

QR678 is a promising treatment for hair loss, with studies suggesting it can reduce hair fall by 50-80% and promote new hair growth in many patients after 6-8 sessions. This patented hair growth formulation contains growth factors and is administered through mesotherapy injections directly into the scalp. According to a recent study 1, autologous platelet concentrates, such as PRP, have shown significant increases in hair density, follicle diameter, and terminal hair density, which are similar to the mechanisms by which QR678 is believed to work. The treatment works by delivering essential growth factors like VEGF, IGF, and KGF directly to hair follicles, potentially stimulating dormant follicles and extending the anagen (growth) phase of the hair cycle.

Some key points to consider when using QR678 for hair loss treatment include:

• The importance of platelet concentration, with higher concentrations having a greater effect on hair density and growth 1
• The potential benefits of combining QR678 with other treatments, such as minoxidil, for enhanced efficacy 1
• The need for maintenance sessions every 3-6 months after the initial course to sustain results
• The potential for QR678 to be more effective for androgenetic alopecia and some forms of alopecia areata, but less effective for scarring alopecias or advanced hair loss

It's also worth noting that while QR678 shows promise, more research is needed to fully establish its efficacy and optimal treatment protocols. However, based on the current evidence, QR678 appears to be a safe and effective treatment option for hair loss, with minimal side effects and significant potential for promoting new hair growth. As with any treatment, it's essential to consult with a healthcare professional to determine the best course of treatment for individual cases of hair loss.

From the Research

Efficacy of QR678 for Treating Hair Loss

• QR678 has been studied as a treatment for hair loss, particularly for Male Androgenetic Alopecia (Male pattern hair loss) 2.
• A prospective, comparative, single-blind study compared the efficacy of QR678 therapy versus PRP in the treatment of Male Androgenetic Alopecia, and found that QR678 resulted in 100% reduction in hair fall at the end of 6 months, which was maintained for 1 year 2.
• Video microscopic evaluation showed that hair density, terminal hair density, vellus hair density, and shaft diameter were significantly better in the QR678 group than the PRP group (P < .005) 2.
• Another study found that QR678 Neo® in combination with intralesional steroids therapy proved to be significantly beneficial, efficient, and can be considered as a safer treatment option for alopecia areata 3.
• QR678 Neo® has also been found to be effective in treating hair loss in Covid-19-induced persistent Telogen Effluvium, with 89% of patients showing excellent hair growth and significant reduction in hair fall 4.

Comparison with Other Treatments

• A study compared the efficacy of oral finasteride and 5% topical minoxidil in male androgenetic alopecia, and found that both drugs were effective and safe, although oral finasteride treatment was more effective (p < 0.05) 5.
• However, QR678 has been found to be more beneficial for Male Androgenetic Alopecia compared to PRP 2.
• The bioengineered formulation of QR678 proved to be more beneficial for Male Androgenetic Alopecia compared to PRP, and can be considered as a safer treatment option for alopecia areata when used in combination with intralesional steroids therapy 2, 3.

Mechanism of Action

• The exact mechanism of action of QR678 is not fully understood, but it is believed to promote hair growth by increasing hair density, terminal hair density, vellus hair density, and shaft diameter 2.
• QR678 Neo® has been found to reduce hair fall, improve hair regrowth, and increase hair density in patients with Covid-19-induced persistent Telogen Effluvium 4.